Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Insulin Infusion Systems | 20 | 2019 | 217 | 4.130 |
Why?
|
Blood Glucose | 63 | 2021 | 6391 | 3.770 |
Why?
|
Insulin | 57 | 2021 | 6597 | 3.370 |
Why?
|
Pancreas, Artificial | 8 | 2018 | 54 | 3.360 |
Why?
|
Diabetes Mellitus, Type 1 | 23 | 2019 | 3415 | 2.430 |
Why?
|
Hypoglycemic Agents | 24 | 2021 | 3085 | 1.750 |
Why?
|
Blood Glucose Self-Monitoring | 9 | 2019 | 467 | 1.520 |
Why?
|
Monitoring, Physiologic | 13 | 2017 | 1779 | 1.490 |
Why?
|
Hyperglycemia | 18 | 2021 | 1376 | 1.230 |
Why?
|
Hypoglycemia | 12 | 2017 | 883 | 1.140 |
Why?
|
Cardiac Output | 5 | 2013 | 831 | 1.120 |
Why?
|
Dietary Fats | 5 | 2019 | 1995 | 1.060 |
Why?
|
Islets of Langerhans | 11 | 2008 | 1341 | 0.820 |
Why?
|
Algorithms | 22 | 2019 | 14033 | 0.780 |
Why?
|
Glucose | 17 | 2017 | 4347 | 0.780 |
Why?
|
Biosensing Techniques | 7 | 2011 | 650 | 0.740 |
Why?
|
Critical Illness | 7 | 2019 | 2723 | 0.670 |
Why?
|
Models, Biological | 24 | 2013 | 9469 | 0.670 |
Why?
|
Postprandial Period | 8 | 2019 | 315 | 0.670 |
Why?
|
Extracellular Fluid | 3 | 2010 | 165 | 0.630 |
Why?
|
Models, Theoretical | 4 | 2018 | 3575 | 0.560 |
Why?
|
Calibration | 7 | 2018 | 818 | 0.550 |
Why?
|
Computer Simulation | 8 | 2013 | 6241 | 0.540 |
Why?
|
Insulin Resistance | 9 | 2015 | 3964 | 0.430 |
Why?
|
Infant, Premature | 3 | 2019 | 2107 | 0.420 |
Why?
|
Diet, Fat-Restricted | 1 | 2015 | 329 | 0.420 |
Why?
|
Thermodilution | 1 | 2012 | 50 | 0.420 |
Why?
|
Insulin-Secreting Cells | 4 | 2013 | 901 | 0.390 |
Why?
|
Glucose Clamp Technique | 14 | 2008 | 263 | 0.360 |
Why?
|
Infusion Pumps, Implantable | 2 | 2009 | 158 | 0.360 |
Why?
|
Dietary Carbohydrates | 6 | 2016 | 891 | 0.360 |
Why?
|
Extracorporeal Circulation | 1 | 2011 | 181 | 0.350 |
Why?
|
Diagnostic Equipment | 1 | 2009 | 11 | 0.340 |
Why?
|
Self Care | 1 | 2015 | 796 | 0.340 |
Why?
|
Circadian Rhythm | 4 | 2018 | 2576 | 0.340 |
Why?
|
Patient Simulation | 1 | 2012 | 298 | 0.330 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2012 | 506 | 0.330 |
Why?
|
Intensive Care Units, Pediatric | 7 | 2019 | 1017 | 0.330 |
Why?
|
Automation | 4 | 2009 | 586 | 0.330 |
Why?
|
Extracellular Space | 4 | 2000 | 563 | 0.320 |
Why?
|
Glucose Tolerance Test | 9 | 2005 | 1178 | 0.320 |
Why?
|
Critical Care | 3 | 2021 | 2697 | 0.310 |
Why?
|
Feedback, Physiological | 1 | 2011 | 476 | 0.310 |
Why?
|
Cerebral Hemorrhage | 1 | 2019 | 2656 | 0.290 |
Why?
|
Cross-Over Studies | 4 | 2019 | 2079 | 0.280 |
Why?
|
Infusions, Parenteral | 1 | 2006 | 397 | 0.270 |
Why?
|
Monitoring, Ambulatory | 3 | 2009 | 354 | 0.270 |
Why?
|
Patient Compliance | 1 | 2015 | 2690 | 0.240 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2578 | 0.230 |
Why?
|
Diabetic Ketoacidosis | 3 | 2014 | 253 | 0.230 |
Why?
|
Saline Solution, Hypertonic | 2 | 2014 | 114 | 0.210 |
Why?
|
Mannitol | 2 | 2014 | 180 | 0.210 |
Why?
|
Respiratory Insufficiency | 3 | 2019 | 1230 | 0.210 |
Why?
|
Dogs | 13 | 2011 | 3839 | 0.210 |
Why?
|
Child, Preschool | 15 | 2019 | 42232 | 0.200 |
Why?
|
Reference Values | 9 | 2007 | 4920 | 0.200 |
Why?
|
Humans | 70 | 2021 | 761596 | 0.200 |
Why?
|
Anemia | 1 | 2011 | 1509 | 0.190 |
Why?
|
Male | 54 | 2021 | 360846 | 0.190 |
Why?
|
Equipment Design | 7 | 2018 | 3511 | 0.180 |
Why?
|
Fats | 1 | 2001 | 99 | 0.180 |
Why?
|
Intensive Care Units | 1 | 2014 | 3744 | 0.180 |
Why?
|
Infant | 14 | 2018 | 36193 | 0.180 |
Why?
|
Dietary Proteins | 2 | 2016 | 952 | 0.180 |
Why?
|
Electrocardiography | 1 | 2013 | 6377 | 0.170 |
Why?
|
Echocardiography | 1 | 2012 | 4989 | 0.170 |
Why?
|
Lymph | 3 | 1996 | 77 | 0.170 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2021 | 197 | 0.170 |
Why?
|
Drug Dosage Calculations | 2 | 2021 | 117 | 0.170 |
Why?
|
Oxygen | 1 | 2011 | 4227 | 0.170 |
Why?
|
Heart | 1 | 2012 | 4404 | 0.160 |
Why?
|
Brain Edema | 2 | 2014 | 604 | 0.160 |
Why?
|
Diabetes Mellitus | 4 | 2010 | 5841 | 0.160 |
Why?
|
Infant, Newborn | 11 | 2019 | 26202 | 0.150 |
Why?
|
Risk Assessment | 1 | 2019 | 23996 | 0.140 |
Why?
|
Female | 33 | 2021 | 392705 | 0.140 |
Why?
|
Blood Specimen Collection | 1 | 2018 | 238 | 0.140 |
Why?
|
Analysis of Variance | 5 | 2013 | 6228 | 0.130 |
Why?
|
Glycemic Index | 2 | 2016 | 396 | 0.130 |
Why?
|
Digestion | 1 | 2015 | 53 | 0.130 |
Why?
|
Intensive Care, Neonatal | 1 | 2017 | 199 | 0.130 |
Why?
|
Postoperative Complications | 2 | 2015 | 15633 | 0.130 |
Why?
|
Lactates | 3 | 2011 | 405 | 0.130 |
Why?
|
Adaptation, Physiological | 2 | 2001 | 1301 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8527 | 0.120 |
Why?
|
Reproducibility of Results | 6 | 2015 | 20100 | 0.120 |
Why?
|
Matched-Pair Analysis | 1 | 2015 | 284 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2018 | 10766 | 0.120 |
Why?
|
Time Factors | 14 | 2012 | 39969 | 0.120 |
Why?
|
Adult | 20 | 2019 | 221210 | 0.120 |
Why?
|
Asthma | 1 | 2013 | 6234 | 0.120 |
Why?
|
Middle Aged | 16 | 2019 | 220921 | 0.120 |
Why?
|
Heart Rate | 4 | 2013 | 4195 | 0.120 |
Why?
|
Kinetics | 9 | 2008 | 6374 | 0.110 |
Why?
|
Infusions, Intravenous | 7 | 2007 | 2217 | 0.110 |
Why?
|
C-Peptide | 3 | 2004 | 440 | 0.110 |
Why?
|
Child | 13 | 2021 | 80158 | 0.110 |
Why?
|
Eating | 3 | 2012 | 1539 | 0.110 |
Why?
|
Adolescent | 14 | 2019 | 88326 | 0.110 |
Why?
|
Regional Blood Flow | 2 | 2012 | 1496 | 0.110 |
Why?
|
Gastric Emptying | 1 | 2015 | 242 | 0.110 |
Why?
|
United States Food and Drug Administration | 2 | 2012 | 1664 | 0.110 |
Why?
|
Regression Analysis | 3 | 2012 | 6345 | 0.110 |
Why?
|
Apoptosis | 1 | 2009 | 9490 | 0.110 |
Why?
|
Splanchnic Circulation | 1 | 1993 | 119 | 0.100 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2010 | 1496 | 0.100 |
Why?
|
Risk | 2 | 2015 | 9610 | 0.100 |
Why?
|
Receptor, Insulin | 1 | 1996 | 836 | 0.100 |
Why?
|
Young Adult | 7 | 2019 | 59260 | 0.100 |
Why?
|
Hemodynamics | 2 | 2013 | 4160 | 0.100 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1175 | 0.100 |
Why?
|
Infant, Premature, Diseases | 1 | 2017 | 710 | 0.100 |
Why?
|
Lymphatic System | 1 | 1993 | 254 | 0.100 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2013 | 123 | 0.100 |
Why?
|
Vascular Resistance | 2 | 2011 | 930 | 0.090 |
Why?
|
Treatment Outcome | 7 | 2018 | 64685 | 0.090 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2012 | 241 | 0.090 |
Why?
|
Food | 1 | 2016 | 774 | 0.090 |
Why?
|
Prediabetic State | 1 | 1996 | 545 | 0.090 |
Why?
|
Gestational Age | 1 | 2019 | 3577 | 0.090 |
Why?
|
Hernia, Diaphragmatic | 1 | 2011 | 245 | 0.080 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2012 | 150 | 0.080 |
Why?
|
Prospective Studies | 7 | 2017 | 54423 | 0.080 |
Why?
|
Tolbutamide | 3 | 1997 | 23 | 0.080 |
Why?
|
Electrochemical Techniques | 1 | 2009 | 94 | 0.080 |
Why?
|
Intention to Treat Analysis | 3 | 2017 | 413 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3415 | 0.080 |
Why?
|
Homeostasis | 3 | 2005 | 3323 | 0.080 |
Why?
|
Body Composition | 1 | 1998 | 2426 | 0.080 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2759 | 0.080 |
Why?
|
Muscles | 1 | 1993 | 1576 | 0.080 |
Why?
|
Oximetry | 1 | 2011 | 459 | 0.080 |
Why?
|
Hyperinsulinism | 2 | 2005 | 400 | 0.070 |
Why?
|
Endothelial Growth Factors | 2 | 2001 | 673 | 0.070 |
Why?
|
Blood Pressure | 3 | 2012 | 8481 | 0.070 |
Why?
|
Pain Measurement | 1 | 2018 | 3551 | 0.070 |
Why?
|
Thoracic Surgery | 1 | 2014 | 722 | 0.070 |
Why?
|
Injections, Intravenous | 4 | 1998 | 1379 | 0.070 |
Why?
|
Area Under Curve | 1 | 2011 | 1638 | 0.070 |
Why?
|
Lymphokines | 2 | 2001 | 927 | 0.070 |
Why?
|
Sex Characteristics | 1 | 1998 | 2639 | 0.070 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2012 | 366 | 0.070 |
Why?
|
Fasting | 2 | 2012 | 1603 | 0.070 |
Why?
|
Dexmedetomidine | 1 | 2011 | 319 | 0.070 |
Why?
|
Conscious Sedation | 1 | 2011 | 532 | 0.070 |
Why?
|
Animals | 27 | 2011 | 168475 | 0.070 |
Why?
|
Drug Administration Routes | 1 | 2006 | 150 | 0.070 |
Why?
|
Artificial Organs | 1 | 2008 | 150 | 0.070 |
Why?
|
3-O-Methylglucose | 2 | 1996 | 37 | 0.070 |
Why?
|
Proteins | 2 | 1998 | 6032 | 0.070 |
Why?
|
Adipose Tissue | 1 | 1998 | 3313 | 0.060 |
Why?
|
Bronchiolitis | 1 | 2012 | 485 | 0.060 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2001 | 740 | 0.060 |
Why?
|
Infant, Newborn, Diseases | 1 | 2011 | 589 | 0.060 |
Why?
|
Fatty Acids, Nonesterified | 5 | 2000 | 393 | 0.060 |
Why?
|
Hemoglobins | 1 | 2011 | 1526 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36426 | 0.060 |
Why?
|
Boston | 2 | 2015 | 9327 | 0.060 |
Why?
|
Blood Transfusion | 1 | 2011 | 1301 | 0.060 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2009 | 710 | 0.060 |
Why?
|
Puberty | 1 | 2007 | 501 | 0.060 |
Why?
|
Cardiovascular System | 1 | 2011 | 834 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2016 | 5247 | 0.060 |
Why?
|
Body Mass Index | 4 | 2006 | 12953 | 0.060 |
Why?
|
Aged | 7 | 2016 | 169310 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2009 | 15266 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4431 | 0.060 |
Why?
|
Carbon Radioisotopes | 2 | 1996 | 561 | 0.060 |
Why?
|
Heart Failure | 2 | 2019 | 11671 | 0.060 |
Why?
|
Age Factors | 2 | 2018 | 18399 | 0.060 |
Why?
|
Capsules | 2 | 2001 | 191 | 0.050 |
Why?
|
Hypnotics and Sedatives | 1 | 2011 | 1179 | 0.050 |
Why?
|
Biological Transport | 4 | 1996 | 2091 | 0.050 |
Why?
|
Injections, Subcutaneous | 1 | 2005 | 681 | 0.050 |
Why?
|
Postoperative Period | 3 | 2017 | 1814 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2013 | 2113 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2006 | 1119 | 0.050 |
Why?
|
Recovery of Function | 1 | 2012 | 2979 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 1996 | 4948 | 0.050 |
Why?
|
Liver | 5 | 1998 | 7528 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2021 | 4853 | 0.050 |
Why?
|
Rats | 8 | 2001 | 23741 | 0.050 |
Why?
|
Pancreas | 1 | 2008 | 1691 | 0.050 |
Why?
|
Glucagon | 3 | 1997 | 532 | 0.050 |
Why?
|
Portal Vein | 3 | 1998 | 431 | 0.050 |
Why?
|
Artifacts | 1 | 2009 | 1911 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 2 | 2013 | 3627 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2021 | 80647 | 0.040 |
Why?
|
Receptors, Growth Factor | 1 | 2001 | 326 | 0.040 |
Why?
|
Genes, myc | 1 | 2001 | 390 | 0.040 |
Why?
|
Tissue Distribution | 2 | 1995 | 2264 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2009 | 12149 | 0.040 |
Why?
|
Alginates | 1 | 2001 | 248 | 0.040 |
Why?
|
Pilot Projects | 2 | 2016 | 8633 | 0.040 |
Why?
|
Models, Statistical | 2 | 2009 | 5079 | 0.040 |
Why?
|
Gene Expression | 2 | 2001 | 7581 | 0.040 |
Why?
|
Stroke Volume | 1 | 2012 | 5496 | 0.040 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2001 | 314 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 4 | 2001 | 8181 | 0.040 |
Why?
|
Glucocorticoids | 1 | 2007 | 2161 | 0.040 |
Why?
|
Body Constitution | 1 | 1998 | 273 | 0.040 |
Why?
|
Radioisotope Dilution Technique | 1 | 1996 | 71 | 0.040 |
Why?
|
Somatostatin | 2 | 1997 | 447 | 0.040 |
Why?
|
Hindlimb | 2 | 1996 | 513 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2001 | 829 | 0.030 |
Why?
|
Obesity | 2 | 1998 | 12947 | 0.030 |
Why?
|
Inulin | 2 | 1993 | 67 | 0.030 |
Why?
|
Tritium | 1 | 1996 | 708 | 0.030 |
Why?
|
Mitosis | 1 | 2001 | 1188 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1998 | 1625 | 0.030 |
Why?
|
Stereoisomerism | 1 | 1996 | 614 | 0.030 |
Why?
|
Cross Infection | 2 | 2016 | 1422 | 0.030 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2017 | 189 | 0.030 |
Why?
|
Methylglucosides | 1 | 1995 | 35 | 0.030 |
Why?
|
Models, Neurological | 4 | 1988 | 1769 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2001 | 988 | 0.030 |
Why?
|
Lipolysis | 1 | 1996 | 212 | 0.030 |
Why?
|
Risk Factors | 2 | 2019 | 74213 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1574 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2011 | 4671 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 2016 | 539 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15843 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1626 | 0.030 |
Why?
|
United States | 2 | 2012 | 72340 | 0.030 |
Why?
|
Hospitalization | 1 | 2013 | 10721 | 0.030 |
Why?
|
Thorax | 2 | 1994 | 555 | 0.030 |
Why?
|
Length of Stay | 2 | 2017 | 6426 | 0.030 |
Why?
|
Leptin | 2 | 1998 | 1597 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 1993 | 361 | 0.030 |
Why?
|
Sodium Chloride | 1 | 1995 | 587 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2017 | 5293 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 1993 | 130 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2000 | 1349 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2004 | 2226 | 0.030 |
Why?
|
Triglycerides | 1 | 2000 | 2461 | 0.030 |
Why?
|
Femoral Artery | 1 | 1996 | 826 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2016 | 909 | 0.020 |
Why?
|
Rats, Wistar | 1 | 1995 | 1848 | 0.020 |
Why?
|
Mathematics | 4 | 1998 | 707 | 0.020 |
Why?
|
Respiratory Rate | 1 | 2012 | 176 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2021 | 2220 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 1993 | 1031 | 0.020 |
Why?
|
Rats, Inbred Lew | 2 | 2001 | 1157 | 0.020 |
Why?
|
Lipids | 1 | 2000 | 3341 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2001 | 748 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 2011 | 1122 | 0.020 |
Why?
|
Visual Perception | 2 | 1988 | 1389 | 0.020 |
Why?
|
Research Design | 2 | 2013 | 6180 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 2013 | 1092 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 14665 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2001 | 11904 | 0.020 |
Why?
|
Postoperative Care | 1 | 2013 | 1468 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2508 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 1993 | 1265 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2319 | 0.020 |
Why?
|
Skin | 1 | 1999 | 4484 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2016 | 2630 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 1995 | 2691 | 0.010 |
Why?
|
Aging | 2 | 2007 | 8710 | 0.010 |
Why?
|
Transcription Factors | 2 | 2001 | 12130 | 0.010 |
Why?
|
Myocarditis | 1 | 2012 | 788 | 0.010 |
Why?
|
Safety | 1 | 2009 | 1149 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 2013 | 1529 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6312 | 0.010 |
Why?
|
Neurons | 3 | 1988 | 9463 | 0.010 |
Why?
|
RNA, Messenger | 3 | 2001 | 12794 | 0.010 |
Why?
|
Nonmuscle Myosin Type IIB | 1 | 2001 | 21 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22176 | 0.010 |
Why?
|
TATA-Box Binding Protein | 1 | 2001 | 99 | 0.010 |
Why?
|
Software | 1 | 1995 | 4434 | 0.010 |
Why?
|
Clonidine | 1 | 2001 | 169 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2001 | 193 | 0.010 |
Why?
|
Endothelium | 2 | 1994 | 765 | 0.010 |
Why?
|
Kidney | 1 | 1995 | 7048 | 0.010 |
Why?
|
Myosin Heavy Chains | 1 | 2001 | 405 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2001 | 3492 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2001 | 795 | 0.010 |
Why?
|
Phenotype | 1 | 1996 | 16592 | 0.010 |
Why?
|
Cytosol | 1 | 2001 | 888 | 0.010 |
Why?
|
Diffusion | 1 | 2000 | 814 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2001 | 558 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2001 | 664 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2001 | 619 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2001 | 1463 | 0.010 |
Why?
|
Proinsulin | 1 | 1997 | 135 | 0.010 |
Why?
|
Least-Squares Analysis | 1 | 1998 | 369 | 0.010 |
Why?
|
Hormones | 1 | 2001 | 869 | 0.010 |
Why?
|
DNA Primers | 1 | 2001 | 2820 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39106 | 0.010 |
Why?
|
Patient Selection | 1 | 2008 | 4244 | 0.010 |
Why?
|
Cadherins | 1 | 2001 | 903 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21355 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2001 | 18966 | 0.010 |
Why?
|
Glycerol | 1 | 1996 | 274 | 0.010 |
Why?
|
Femoral Vein | 1 | 1995 | 153 | 0.010 |
Why?
|
Mathematical Computing | 1 | 1995 | 142 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4576 | 0.010 |
Why?
|
DNA-Binding Proteins | 2 | 2001 | 9610 | 0.010 |
Why?
|
Alanine | 1 | 1995 | 609 | 0.010 |
Why?
|
Electricity | 1 | 1993 | 181 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 1998 | 1258 | 0.010 |
Why?
|
Cholesterol | 1 | 2000 | 2905 | 0.010 |
Why?
|
Antigens, CD | 1 | 2001 | 4001 | 0.010 |
Why?
|
Forecasting | 1 | 1999 | 2928 | 0.010 |
Why?
|
Base Sequence | 1 | 2001 | 12441 | 0.010 |
Why?
|
Body Weight | 1 | 2001 | 4618 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6534 | 0.010 |
Why?
|
Graft Survival | 1 | 2000 | 3820 | 0.010 |
Why?
|
Myocardium | 1 | 2001 | 4725 | 0.000 |
Why?
|
Calcium | 1 | 2001 | 5722 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20568 | 0.000 |
Why?
|
Perceptual Masking | 1 | 1988 | 90 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1993 | 58984 | 0.000 |
Why?
|
Veins | 1 | 1992 | 768 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2006 | 18255 | 0.000 |
Why?
|
Arteries | 1 | 1992 | 1123 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 2001 | 5799 | 0.000 |
Why?
|
Cybernetics | 1 | 1985 | 7 | 0.000 |
Why?
|
Blood-Brain Barrier | 1 | 1991 | 1027 | 0.000 |
Why?
|
Neural Conduction | 1 | 1986 | 441 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2001 | 22174 | 0.000 |
Why?
|
Evoked Potentials, Visual | 1 | 1985 | 417 | 0.000 |
Why?
|
Neural Inhibition | 1 | 1986 | 590 | 0.000 |
Why?
|
Motion Perception | 1 | 1985 | 374 | 0.000 |
Why?
|
Synaptic Transmission | 1 | 1987 | 1173 | 0.000 |
Why?
|
Reaction Time | 1 | 1986 | 2089 | 0.000 |
Why?
|
Mice | 1 | 2001 | 81539 | 0.000 |
Why?
|
Signal Transduction | 1 | 1995 | 23447 | 0.000 |
Why?
|